From Blind Spot to Running View.

Payer policies, pricing intelligence, and launch sequencing grounded in the same evidence base your team runs on. Know what the market will say, before you say anything to the market.

Trusted by over 200,000+ researchers

Trusted by over 200,000+ researchers

Trusted by over 200,000+ researchers

  • Christopher newport university
  • SAIT
  • MIT
  • Penn
  • Standford university
  • University of oxford
  • NASA
  • Christopher newport university
  • McKmsey & Company

Trusted by 200,+ institutions and individuals

  • Christopher newport university
  • SAIT
  • MIT
  • Penn
  • Standford university
  • University of oxford
  • NASA
  • Christopher newport university
  • McKmsey & Company

Trusted by 200,000+ institutions and individuals

  • Christopher newport university
  • SAIT
  • MIT
  • Penn
  • Standford university
  • University of oxford
  • NASA
  • Christopher newport university
  • McKmsey & Company

12+

HTA Bodies Supported

100+

Payer Policies Monitored

60-Day

Earlier Signal vs Claims Lag

250M+

Abstracts Accessible

Solution

Every payer, every policy, one workspace.

Payer Policy Monitoring

Continuous tracking across national payers, private insurers, and PBM formularies. When a policy changes, you know in days, not the next quarterly claims cycle.

Pricing & Reference Analysis

Net price modelling, willingness to pay synthesis, and international reference pricing scenarios pulled from published analogs and active payer data.

Launch Sequencing

Model the optimal market order across reference pricing rules, HTA timelines, and revenue exposure. Re-run the scenario the moment an input moves.

HTA Body Intelligence

NICE, G-BA, HAS, CADTH, PBAC, EU JCA. Each body's decision criteria, recent precedents, and evidence expectations mapped against your target indication.

Payer Value Story

Clinical differentiation, economic impact, and patient outcomes synthesised into one evidence-backed narrative. Retailored for every payer audience without rebuilding from scratch

Competitive Landscape

How analog products priced, where they won coverage, where they lost it. Every claim linked to the policy, publication, or filing it came from.

Processes

From Landscape to Launch. The new leading market strategy pipeline

Each step is connected to the last, so the strategy evolves as the market does

Step 01

Landscape

Competitive treatments, guidelines, pricing, and reimbursement pathways mapped across every target market your team cares about.

Step 02

Strategy

Pricing corridors, access scenarios, and launch sequence drafted against reference pricing rules and HTA decision timelines.

Step 03

Evidence

Gap analysis against HTA and payer expectations. Synthesis of clinical and economic evidence drawn from the same source library your HEOR team already uses.

Step 04

Engage

Payer value stories, advisory board briefing packs, and KOL maps prepared for structured validation before launch decisions are locked.

Step 05

Launch & Monitor

Policy changes, formulary shifts, and competitor moves tracked continuously post-launch, so access issues surface in days rather than quarters.

Deliverables

What you get

Access Strategy

Market by market access plans covering pricing, reimbursement pathways, and sequencing logic. Editable, exportable, and always tied to the evidence behind each recommendation.

Access Strategy

Market by market access plans covering pricing, reimbursement pathways, and sequencing logic. Editable, exportable, and always tied to the evidence behind each recommendation.

Access Strategy

Market by market access plans covering pricing, reimbursement pathways, and sequencing logic. Editable, exportable, and always tied to the evidence behind each recommendation.

Pricing Analytics

Net price analysis, reference pricing exposure, and willingness-to-pay scenarios modelled from payer data and published analogs.

Pricing Analytics

Net price analysis, reference pricing exposure, and willingness-to-pay scenarios modelled from payer data and published analogs.

Pricing Analytics

Net price analysis, reference pricing exposure, and willingness-to-pay scenarios modelled from payer data and published analogs.

Landscape Reports

Competitive treatment, guideline, and reimbursement assessments across target geographies. Every claim traceable to its source.

Landscape Reports

Competitive treatment, guideline, and reimbursement assessments across target geographies. Every claim traceable to its source.

Landscape Reports

Competitive treatment, guideline, and reimbursement assessments across target geographies. Every claim traceable to its source.

Payer Value Story

Evidence-backed value stories built for payer audiences, retailored per stakeholder without rebuilding the underlying evidence each time.

Payer Value Story

Evidence-backed value stories built for payer audiences, retailored per stakeholder without rebuilding the underlying evidence each time.

Payer Value Story

Evidence-backed value stories built for payer audiences, retailored per stakeholder without rebuilding the underlying evidence each time.

Why Access Teams Are Switching to AnswerThis

Every payer policy in one place

Stop stitching together Policy Reporter emails, formulary feeds, and manual PDF comparisons. One workspace, every policy, change log included.

Catch policy shifts before claims do

Most teams learn a payer tightened step therapy 60 to 90 days after it happens. AnswerThis flags the change inside the policy document itself, the week it publishes.

Catch policy shifts before claims do

Most teams learn a payer tightened step therapy 60 to 90 days after it happens. AnswerThis flags the change inside the policy document itself, the week it publishes.

One evidence base. Every payer audience.

The same clinical and economic evidence reused across value dossiers, advisory boards, payer decks, and HTA submissions. No rebuilding the narrative from scratch for each stakeholder.

One evidence base. Every payer audience.

The same clinical and economic evidence reused across value dossiers, advisory boards, payer decks, and HTA submissions. No rebuilding the narrative from scratch for each stakeholder.

Launch sequencing you can actually re-run

When a competitor moves up a timeline or a country changes its reference pricing rule, your sequence model updates in the workspace. Not in a consultant's Excel file two weeks later.

Launch sequencing you can actually re-run

When a competitor moves up a timeline or a country changes its reference pricing rule, your sequence model updates in the workspace. Not in a consultant's Excel file two weeks later.

Ready to get started

Tell us about your project and we'll show you how we can help.

Ready to get started

Tell us about your project and we'll show you how we can help.

Ready to get started

Tell us about your project and we'll show you how we can help.

AI-powered evidence generation for life sciences. Structured literature reviews, HEOR, market access, and reimbursement strategy — delivered end-to-end.

© 2026 AnswerThis. All rights reserved.

Terms of Service

AI-powered evidence generation for life sciences. Structured literature reviews, HEOR, market access, and reimbursement strategy — delivered end-to-end.

© 2026 AnswerThis. All rights reserved.

Terms of Service

AI-powered evidence generation for life sciences. Structured literature reviews, HEOR, market access, and reimbursement strategy — delivered end-to-end.

© 2026 AnswerThis. All rights reserved.

Terms of Service

Create a free website with Framer, the website builder loved by startups, designers and agencies.